999 related articles for article (PubMed ID: 18978503)
1. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
[TBL] [Abstract][Full Text] [Related]
2. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
3. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G
J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731
[TBL] [Abstract][Full Text] [Related]
4. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
Glasper A; Gossop M; de Wet C; Reed L; Bearn J
Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
[TBL] [Abstract][Full Text] [Related]
5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
6. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
7. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
[TBL] [Abstract][Full Text] [Related]
8. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
Zarghami M; Masoum B; Shiran MR
J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
[TBL] [Abstract][Full Text] [Related]
9. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
10. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
Vaupel DB; Jasinski DR
J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405
[TBL] [Abstract][Full Text] [Related]
11. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
12. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
13. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
Lawlor PG; Turner KS; Hanson J; Bruera ED
Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
[TBL] [Abstract][Full Text] [Related]
14. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
[TBL] [Abstract][Full Text] [Related]
15. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of methadone.
Layson-Wolf C; Goode JV; Small RE
J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
18. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients.
Hay JL; White JM; Bochner F; Somogyi AA
Eur J Pain; 2008 Oct; 12(7):926-33. PubMed ID: 18262451
[TBL] [Abstract][Full Text] [Related]
20. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
